Conexeu Sciences, Inc. (CNXU)
4.97
-0.30
(-5.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.09
+0.12
(+2.41%)
Pre-Market: 20:00
Conexeu Sciences Cash from Investing (Quarterly) : -0.0301M for April 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -0.0301M |
| January 31, 2026 |
| Date | Value |
|---|---|
| April 30, 2025 | -0.0048M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.197B |
| Vericel Corp. | -2.82M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.804M |
| Cash from Financing (Quarterly) | 2.427M |
| Free Cash Flow Per Share (Quarterly) | -0.0685 |
| Free Cash Flow to Equity (Quarterly) | -1.834M |
| Free Cash Flow to Firm (Quarterly) | -1.830M |